|
|
Volumn 11, Issue 3, 1999, Pages 147-153
|
|
Antiretroviral drug guidelines for the treatment of HIV infection. Should protease inhibitors always be included in the initial regimen or not?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABACAVIR;
ANTIRETROVIRUS AGENT;
DELAVIRDINE;
DIDANOSINE;
EFAVIRENZ;
HYDROXYUREA;
LAMIVUDINE;
NEVIRAPINE;
PROTEINASE INHIBITOR;
RIFAMPICIN;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
STAVUDINE;
ZIDOVUDINE;
ALLERGIC REACTION;
BLEEDING;
DIABETES MELLITUS;
DRUG ANTAGONISM;
DRUG MIXTURE;
HEMOLYTIC ANEMIA;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPERLIPIDEMIA;
NEPHROLITHIASIS;
PATIENT COMPLIANCE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
REVIEW;
VIRUS LOAD;
VIRUS RESISTANCE;
|
|
EID: 0033006379
PISSN: 11738804
EISSN: None
Source Type: Journal
DOI: 10.2165/00063030-199911030-00001 Document Type: Review |
|
Times cited : (3)
|
|
References (61)
|
